
Obalon Therapeutics, Inc. OBLN
Obalon Therapeutics, Inc. Total Liabilities 2011-2025 | OBLN
Annual Total Liabilities Obalon Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 5.95 M | 4.54 M | 17.3 M | 18 M | 14.5 M | 69.4 M | 60.6 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 69.4 M | 4.54 M | 27.2 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
165 M | - | - | $ 17.2 B | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 21.09 | 0.6 % | $ 3.01 B | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
281 M | $ 9.27 | -0.43 % | $ 666 M | ||
|
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.51 | 2.09 % | $ 122 M | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 95.87 | -0.16 % | $ 141 B | ||
|
Bio-Rad Laboratories
BIO
|
2.79 B | $ 303.07 | -0.27 % | $ 8.55 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Electromed
ELMD
|
10.6 M | $ 28.32 | -0.63 % | $ 239 M | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 48.17 | 0.33 % | $ 7.18 K | ||
|
Abbott Laboratories
ABT
|
36.6 B | $ 124.83 | - | $ 217 B | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.27 | -3.97 % | $ 122 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
InMode Ltd.
INMD
|
81.9 M | $ 14.8 | 1.22 % | $ 1.17 B | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.16 | -5.69 % | $ 18.7 M | ||
|
IRadimed Corporation
IRMD
|
11.5 M | $ 97.61 | 0.16 % | $ 1.24 B | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
LivaNova PLC
LIVN
|
1.19 B | $ 62.08 | -1.26 % | $ 3.37 B | ||
|
LENSAR
LNSR
|
47.7 M | $ 11.96 | 0.04 % | $ 138 M | ||
|
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
2.36 B | $ 157.99 | -0.24 % | $ 11.8 B | ||
|
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
389 M | $ 0.81 | -2.36 % | $ 83.2 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
13.8 M | $ 13.6 | -3.0 % | $ 368 M | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 14.46 | 0.06 % | $ 94.8 M | ||
|
AxoGen
AXGN
|
99.8 M | $ 32.84 | 0.12 % | $ 1.45 B | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
1.34 B | $ 41.4 | 1.55 % | $ 1.28 B | ||
|
OrthoPediatrics Corp.
KIDS
|
119 M | $ 17.8 | 2.65 % | $ 411 M | ||
|
Globus Medical
GMED
|
1.07 B | $ 88.69 | 0.32 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 12.55 | -0.55 % | $ 966 M | ||
|
Orthofix Medical
OFIX
|
390 M | $ 15.47 | 1.51 % | $ 590 M |